Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IFLO is Breaking Out -- Ignore unavailable to you. Want to Upgrade?

To: James Strauss who wrote (969)	5/21/2000 2:10:00 PM
From: Sergio H	Read Replies (2) \| Respond to of 1018

Jim,good response to Snake Eyes. We're more than aware of what IFLO has and hasn't chosen to share and particularly aware that management's strategy appears to be targeting IFLO as a buyout once a niche is established. I don't have a problem with that. Snake Eyes, did I mention Snake Eyes? A look at some recent Snake Eye posts reveals that he is not only an expert on Pain Buster 2000's market share, Snake Eyes is an expert on PTSC: <I know this stock better than anyone on this thread....> Message 13745394 On the long side, Snake has taken a beating on NANO: Message 13326228 And on VIGN, (ouch): Message 13462604 ...but he's maintained his sense of humor,(even though it is intended to insult): Message 13481840 Now if Snake Eyes has some answers to the questions that he is posing, I might change my opinion, but I am inclined to make use of the IGNORE function for Snake Eyes in the future. Sergio

To: James Strauss who wrote (969)	5/21/2000 3:57:00 PM
From: FastC6	Respond to of 1018

James, Infusystems business is a big yawner...might provide a base of steady income (albeit a small one) and is not in what I would call a booming sector. The real hope and potential for explosive growth was to come from the PainBuster and ON-Q products. It is now becoming evident that these products are not producing the kind of numbers you or I had hoped for....the difference is that I saw it coming sooner than you. . .

To: James Strauss who wrote (969)	6/5/2000 12:57:00 PM
From: Toni Wheeler	Read Replies (1) \| Respond to of 1018

I-Flow Corporation Wins Patent Infringement Lawsuit Against Novacon Corporation <<<LAKE FOREST, Calif.--(BUSINESS WIRE)--June 5, 2000--I-Flow Corporation (Nasdaq: IFLO) announced today that the United States District Court for the Central District of California has ordered Novacon Corporation to immediately stop importing, manufacturing, selling and distributing the DIB elastomeric pump from Japan which infringes the patent for I-Flow's Homepump Eclipse(R) in the United States. "We are extremely pleased with this decision. I-Flow has invested substantial sums of money in developing the Homepump Eclipse and other cost-effective products for the pain management and infusion needs of patients," said Donald M. Earhart, I-Flow's chairman, president and chief executive officer. "We invested the resources necessary to develop the technology incorporated in these products and to patent the technology. We believe the ability to develop innovative technology is one of I-Flow's primary competitive advantages and we always will vigorously defend our proprietary technology from infringement." About I-Flow I-Flow Corporation (www.i-flowcorp.com) designs, develops and markets technically advanced, low cost ambulatory infusion systems that are redefining the standard of care by providing life enhancing, cost effective solutions for pain management and infusion therapy. The statements contained in this release which are not historical facts may be deemed to contain forward-looking statements with respect to events, the occurrence of which involve significant risks and uncertainties, including, without limitation, future demand for the Company's services, competition within the industry, and other risks or uncertainties detailed in the Company's Securities and Exchange Commission filings. ------------------------------------------------------------------------ Contact: I-Flow Corporation Gayle L. Arnold, 949/206-2700 www.i-flowcorp.com or Neil Berkman Associates John Hicks, 310/277-5162 info@BerkmanAssociates.com>>>